Skip to main content
47°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about SRPT
Recent news which mentions SRPT
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
March 01, 2023
Tickers
AMC
BILI
BMR
BRSP
Tags
Market News
GROV
BMR
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 01, 2023
Tickers
BGS
BMR
BRSP
CBIO
Tags
FLGC
OKYO
BGS
From
InvestorPlace
Sarepta Therapeutics (SRPT) Q4 2022 Earnings Call Transcript
February 28, 2023
Tickers
SRPT
Tags
Recent Press Releases
Market News
SRPT
From
Motley Fool
FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments
February 28, 2023
Tickers
BIIB
EWTX
RETA
SPX
Tags
RETA
JP:4523
SRPT
From
MarketWatch
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 28, 2023
Tickers
BLPH
CBIO
CPHI
CUTR
Tags
GDRX
SDGR
CPHI
From
Benzinga
Earnings Scheduled For February 28, 2023
February 28, 2023
Tickers
NFE
NNI
NRDY
NSTG
Tags
VRM
SEAS
RVNC
From
Benzinga
Expert Ratings for Sarepta Therapeutics
February 15, 2023
Tickers
SRPT
Tags
SRPT
Analyst Ratings
Benzinga
From
Benzinga
3 Gene Editing Stocks With the Best Long-Term Potential
January 25, 2023
Tickers
CRSP
GNOM
MYGN
NTLA
Tags
GNOM
NTLA
MYGN
From
InvestorPlace
9 Analysts Have This to Say About Sarepta Therapeutics
January 20, 2023
Tickers
SRPT
Tags
Analyst Ratings
Benzinga
BZI/AAR
From
Benzinga
7 Biotech Stocks That Will Make You Rich in 10 Years
January 18, 2023
Tickers
ABBV
CRSP
CVAC
DIS
Tags
Market News
ABBV
SRPT
From
InvestorPlace
2 Under-the-Radar Biotech Stocks to Buy in 2023
January 06, 2023
Tickers
CRSP
SRPT
VRTX
Tags
Recent Press Releases
Market News
VRTX
From
Motley Fool
BTIG Maintains Buy Rating for Sarepta Therapeutics: Here's What You Need To Know
December 22, 2022
Tickers
SRPT
Tags
Analyst Ratings
Benzinga
Market News
From
Benzinga
2 Top Healthcare Stocks to Buy for the Long Haul
December 09, 2022
Tickers
AZN
GH
SRPT
Tags
SRPT
AZN
Market News
From
Motley Fool
Analyst Ratings for Sarepta Therapeutics
November 03, 2022
Tickers
SRPT
Tags
Benzinga
Analyst Ratings
Market News
From
Benzinga
Sarepta Therapeutics (SRPT) Q3 2022 Earnings Call Transcript
November 03, 2022
Tickers
SRPT
Tags
SRPT
Recent Press Releases
Market News
From
Motley Fool
Earnings Scheduled For November 2, 2022
November 02, 2022
Tickers
QMCO
QRVO
RACE
RARE
Tags
RSI
STRY
WEAV
From
Benzinga
3 Unstoppable Stocks That Could Double in 5 Years
October 29, 2022
Tickers
DNA
NVCR
SRPT
Tags
DNA
Market News
Recent Press Releases
From
Motley Fool
2 Under-the-Radar Biotech Stocks to Buy in 2022
October 19, 2022
Tickers
CRSP
SRPT
Tags
Recent Press Releases
Market News
SRPT
From
Motley Fool
Apple To $177? Plus This Analyst Slashes PT On Opendoor Technologies By About 71%
October 17, 2022
Tickers
AAPL
BILL
LIN
OPEN
Tags
Trading Ideas
Benzinga
Markets
From
Benzinga
7 Analysts Have This to Say About Sarepta Therapeutics
October 13, 2022
Tickers
SRPT
Tags
Market News
BZI/AAR
Analyst Ratings
From
Benzinga
PepGen's Duchenne Candidate Has Potential For Greater Exon Skipping Capabilities At Lower Doses Versus Sarepta's Candidate, Says Analyst
September 28, 2022
Tickers
PEPG
SRPT
Tags
Analyst Ratings
Biotech
Benzinga
From
Benzinga
$6 Million Bet On Sarepta Therapeutics? 3 Stocks Insiders Are Buying
September 16, 2022
Tickers
CNA
COIN
SRPT
Tags
SRPT
CNA
Market News
From
Benzinga
Analyst Ratings for Sarepta Therapeutics
September 08, 2022
Tickers
SRPT
Tags
SRPT
BZI/AAR
Market News
From
Benzinga
A Biotech's Stock Just Hit Year High. This Analyst Expects It To Jump Another 16%
September 08, 2022
Tickers
SRPT
Tags
Trading Ideas
Benzinga
Health Care
From
Benzinga
FDA Lifts Clinical Hold On Sarepta's Dose-Expansion Part Of Duchenne Trial
September 06, 2022
Tickers
SRPT
Tags
Biotech
News
Market News
From
Benzinga
3 Biotech Stocks You Can Buy and Hold for the Next Decade
August 29, 2022
Tickers
CRSP
MYGN
SRPT
Tags
MYGN
Market News
Recent Press Releases
From
Motley Fool
Sarepta In-Licenses Next-Gen AAV Tech Covering Five Indications
August 08, 2022
Tickers
SRPT
Tags
News
Briefs
General
From
Benzinga
Is Biotech Back? This Analyst Sees 18% Upside Potential In This Bio Play
August 08, 2022
Tickers
SRPT
Tags
Topics
Analyst Ratings
Earnings
From
Benzinga
Sarepta's Duchenne Gene Therapy Update Gets Bullish Stance From Analysts
August 03, 2022
Tickers
SRPT
Tags
News
Analyst Ratings
Biotech
From
Benzinga
Sarepta Therapeutics (SRPT) Q2 2022 Earnings Call Transcript
August 02, 2022
Tickers
SRPT
Tags
SRPT
Market News
Recent Press Releases
From
Motley Fool
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
